Fate Therapeutics (FATE)

Fate Therapeutics (FATE) Financial Statements


Fate Therapeutics Financial Overview

Fate Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.909; its P/E ratio is -1.91; Fate Therapeutics is scheduled to report earnings on May 3, 2023, and the estimated EPS forecast is $-0.61. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 44.36M$ 14.98M$ 18.55M$ 18.41M$ 17.07M
Gross Profit-----
EBIT$ -64.42M$ -86.39M$ -83.11M$ -74.47M$ -64.54M
EBITDA$ -59.58M$ -83.20M$ -80.15M$ -71.71M$ -62.33M
Net Income Common Stockholders$ -56.36M$ -83.56M$ -76.11M$ -65.69M$ -68.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 436.23M$ 505.14M$ 568.85M$ 573.77M$ 615.91M
Total Assets$ 705.56M$ 749.35M$ 807.06M$ 858.39M$ 921.46M
Total Debt$ 109.34M$ 110.92M$ 112.30M$ 113.52M$ 114.82M
Net Debt$ -326.89M$ -394.22M$ -456.55M$ -460.25M$ -501.09M
Total Liabilities$ 221.62M$ 231.35M$ 226.58M$ 224.99M$ 242.62M
Stockholders Equity$ 483.94M$ 518.00M$ 580.48M$ 633.39M$ 678.84M
Cash Flow-
Free Cash Flow$ -82.07M$ -63.72M$ -63.29M$ -74.70M$ -88.66M
Operating Cash Flow$ -75.39M$ -55.05M$ -53.16M$ -64.61M$ -70.29M
Investing Cash Flow$ 53.11M$ 80.38M$ 40.29M$ -7.03M$ 71.28M
Financing Cash Flow$ 1.52M$ 1.49M$ 3.41M$ 2.80M$ 3.42M
Currency in USD

Fate Therapeutics Earnings and Revenue History

Fate Therapeutics Debt to Assets

Fate Therapeutics Cash Flow

Fate Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis